findmyKOL

Jose Vazquez, MD

Enriched profile

Division Chief & Professor of Medicine, Division of Infectious Diseases · Medical College of Georgia

ORCIDNPI
Region🇺🇸 Augusta, GA · Southeast · United StatesSpecialtyInfectious DiseaseFocusAntifungal resistance and susceptibility+4
Active KOLLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Jose Vazquez is Division Chief & Professor of Medicine, Division of Infectious Diseases at Medical College of Georgia. OpenAlex indexes 231 publications with 21,215 citations (h-index 62); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Jose A. Vazquez, MD, is Division Chief & Professor of Medicine, Division of Infectious Diseases at Medical College of Georgia, Augusta University. The public record shows 231 publications with 21,215 citations (h-index 62), centered on Antifungal resistance and susceptibility, Fungal Infections and Studies, Pneumocystis jirovecii pneumonia detection and treatment. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 17 companies.

  • Most recent indexed publication: 2026 · Infection and drug resistance
  • Top research focus: Antifungal resistance and susceptibility
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 17 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Pneumonia2 trialsCoronary Artery Disease / ACS1 trialMyocardial Infarction1 trialInfarction1 trialCOVID-191 trialCandidemia1 trialMultiple Myeloma1 trialHIV1 trialHIV Infections1 trialSexually Transmitted Diseases1 trialPneumonia, Pneumocystis1 trialCysts1 trialHeart Failure1 trialSepsis / Serious Bacterial1 trialBacteremia1 trialEndocarditis1 trialMyocarditis1 trialOsteomyelitis1 trialMyelitis1 trial

Research focus

OpenAlex concept fingerprint
Antifungal resistance and susceptibilityFungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatmentNail Diseases and TreatmentsParasitic Diseases Research and Treatment

Drugs & molecules

across trials, industry payments and publications
Rezzayogeneric · RezafunginClinical trialsIndustry payments184Publications3Dalvancegeneric · DalbavancinClinical trialsIndustry payments108Publications1Avycazgeneric · Avibactam / ceftazidimeClinical trialsIndustry payments249Publications

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trialsIndustry payments301Melinta Therapeutics, LLCClinical trialsIndustry payments190Astellas Pharma US IncClinical trialsIndustry payments21

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
231publications

Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.

21,215citations

Total citations across indexed works.

62h-index

Hirsch index (OpenAlex). i10-index 126.

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials
17companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

17 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    100%
    Tetracycline-class Drug51.9%
    Doxycycline Hyclate100%
    Part D<11 patients
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor48.1%
    Juluca100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 27 Aug 2026

1 congress contribution (2024) across ASTRO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jose-vazquez-md-874260ce

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Doximity

    doximity.com/pub/jose-vazquez-md-f1e3bce5

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/jose-vazquez-a565968b

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    expertfile.com/spotlight/7058/Experts-in-the-media---Augusta-s-Dr.-Jose-Vazquez-is-becoming-the-go-to-expert-for-the-coronavirus

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →expertfile.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Ad hoc reviewer: Clinical Infectious Diseases

    Journal of Infectious Diseases, Journal of Critical Illness, Annals of Internal Medicine, Medical Mycology, Mayo Clinic Proceedings, Micologia …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com
  • Member

    Scientific Advisory Board, Mycosis Study Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com
  • Member

    Scientific Advisory Board, Comprehensive AIDS Alliance of Detroit

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Chief

    Antimicrobial Stewardship Program, AU Health / Wellstar

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu
  • Chair

    Institutional Review Board (IRB), Augusta University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →augusta.edu
  • Previously: Professor of Medicine

    Division of Infectious Diseases, Wayne State University School of Medicine; Senior Staff Physician and Director, Infectious and Microbiology Translational Research Center …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.